Profit Or Loss [Abstract]

Captor Therapeutics S.A. - Filing #6216905

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
3 986 PLN
Other income
2 694 PLN
126,000 PLN
Profit (loss) from operating activities
31 709 PLN
12 216 PLN
Finance costs
863,000 PLN
478,000 PLN
Profit (loss) before tax
32 572 PLN
12 694 PLN
Profit (loss) from continuing operations
32 572 PLN
12 694 PLN
Profit (loss)
32 572 PLN
32 572 PLN
32 572 PLN
12 694 PLN
12 694 PLN
12 694 PLN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
32 572 PLN
12 694 PLN
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
789,000
354,000
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
748,000
381,000

Talk to a Data Expert

Have a question? We'll get back to you promptly.